A new study of 5 year old children relates their current allergy symptoms to LOW maternal intake of vitamin D from food (which is strange within the context of current cohort studies that show a INCREASED risk by vitamin D supplement use).
As this is a diabetes study, the sample is highly biased Continue reading Neverending story – vitamin D in pregnancy
A new review [Allergy (2009) vol. 64 (3) pp. 348-353] examines the evidence that
(1) failure to up-regulate the interferon gamma (IFNg) response during infancy is an important determinant of the risk of allergic disease
(2) expression of the IFNg gene in naive T-cells is regulated by epigenetic mechanisms, and
(3) failure to up-regulate IFNg gene expression of naive T-cells associated with low early life microbial exposure.
If we replace “microbial exposure” with Continue reading 1, 2, 3
or briefly vitamin D3. There seems to be another vitamin D /allergy abstract at the forthcoming EAACI congress from the KOALA study. The authors find
Risk for AD was highest for children in the fourth quintile of maternal 25(OH)D level [adjusted odds ratio (aOR) 2.08; 95%CI 1.07-4.03] compared to those in the third quintile; P for trend over the quintiles 0.03]. Continue reading (1S,3Z)-3-[(2E)-2-[(1R,3aR,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
SPQR (is not necessary to be remembered) but certainly TSLP – at least if you are interested in allergy research (see the discussion here 2 years ago) when we knew from a PNAS paper that topical vitamin D3 induces thymic stromal lymphopoietin and triggers atopic dermatitis (in mice). Now there is an update – TSLP even mediates the progression to experimental asthma
vitamin D3 … not only triggers AD as we previously reported but also aggravates experimental allergic asthma induced by ovalbumin sensitization and challenge. Our study, which provides a mouse model to study human “atopic march
will be continued after Continue reading T_S_L_P
The current issue of the blue journal has more stuff on the vitamin D hypothesis (that has been shifted recently into the opposite direction). I agree with the editorial that
Intervention studies of vitamin D in the primary prevention and treatment of asthma raise a number of difficult scientific, ethical, and regulatory issues.
That may be true while the editorial includes the widely quoted myth that immunological effects occur only at high doses Continue reading Shift happens
Thanks to the great audience in Washington DC watching our pro-con show about vitamin D and allergy. Are you still wondering about all the monkeys on my opponent’s slides? Me too…
With having fever from a flu on the way back to Europe, a picture came to my mind showing the 3 apes that are unable to see, hear and speak …
Mail me if there remain any doubts about the Th1 blocking effect of D3 or go to one of the recent reviews – I have take this for granted as it is even in standard textbooks like Roitt’s Immunology. Continue reading Three unwise monkeys
A recent ERJ correspondence letter highlights vitamin D (among other others) as sensitizer at the workplace.
Skin sensitisers are typically more hydrophobic than respiratory sensitisers. Both water-soluble and fat-soluble vitamins are used as additives in the food industry. Exposure at work to both of the above classes of vitamin compounds may occur, resulting in respiratory and skin sensitisation of workers during the manufacturing process.
The hygiene hypothesis usually assumes an “underemployed” system that is directed against self-defined allergen targets – a rather mechanistic view of a half filled barrel. A new Nature paper on memory CD8 T-cells now explains why this view is rather odd Continue reading Another challenge of the hygiene hypothesis
Sorry, I did not find the time to write so much here during this month. I have been revising manuscripts (on asthma genetics and another on the history of vitamin D introduction), traveling to another visit in Bolzano, a meeting in Barcelona and a retreat at Seeon. At present Continue reading Yes, we can
Blood has now also an account on the vitamin hypothesis.
Following some earlier descriptions in Reed 1932, Selye 1962, Wjst 1999 and Wieringa 2008, the discovery frequency seems to increase – a good sign for some progress. Bischoff writes about vitamin A where we have only some limited evidence.
“Endotyping asthma” is a thoughtful review of the complex risk factors and mechanisms involved in asthma pathogenesis. It marks a new direction – away from Th2 immunity towards a bunch of novel disease pathways. The author also touches briefly asthma candidate genes, grouping them into 7 areas Continue reading Endotyping asthma
A study published earlier this year in the Lancet found a 18% reduction in mortality when women obtained supplements during pregnancy until 90 days post partum including additional 800 ug retinol, 200 IU vitamin D, 10 mg vitamin E, 70 mg ascorbic acid, 1.4 mg vitamin B1, 18 mg niacin, 1.9 mg vitamin B6, 2.6 ug vitamin B12, 15 mg zinc, 2 mg copper, 65 ug selenium and 150 ug iodine. Much of the effect will be due to the vitamin D supplementation Continue reading Vitamin D: A 18%! reduction in early infant mortality
A new abstract at the recent ATS congress now clears the 2007 controversy between the Camargo and Gale studies on the effect of vitamin D: Wheezing is not asthma (as the atopy component is missing?). Continue reading Not all that wheezes is asthma
Just for curiosity I am collecting a list of allergy genes that are vitamin D dependent. The list is already rather long but now there is a prominent addition: CD14. Known as asthma gene for many years the vitamin D dependency isn’t such clear. A clever analysis, however, now shows that there is an intermediate step involved Continue reading CD 14 now also on the vitamin+allergy list
Despite the known allergy promoting effect of vitamin D in early childhood, there is mounting evidence that it may have beneficial effects during specific immunotherapy. A paper on “IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model” by researchers from a French allergen company Continue reading Vitamin D as an adjuvans to specific immunotherapy
